Alcohol and Smoking Double to 17x Death Risk in MASLD Patients
Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) who consume alcohol face twice the risk of death. Those who both drink and smoke have a 17-fold higher mortality risk, according to recent studies. This highlights the severe impact of combined alcohol and tobacco use on fatty liver disease outcomes, even in non-overweight individuals.
조선일보·


